Search
Search Results
##search.searchResults.foundPlural##
-
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2268PDF: 1318HTML: 17074Bassan Fig.1: 140Bassan Fig.2: 151Bassan Fig.4: 138Fig.3: 179 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3516PDF: 2392HTML: 1451 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2246PDF: 1811HTML: 139 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2575PDF: 1603HTML: 2349Table1: 188 -
APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA
1649PDF: 643HTML: 2427 -
TDT Positive High-Grade Lymphoma with Myc, BCL2 And BCL6 Rearrangements: a Review of Diagnosis and Treatment TDT POSITIVE HIGH-GRADE LYMPHOMA WITH MYC, BCL2 AND BCL6 REARRANGEMENTS.
1680PDF: 757HTML: 486 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3655PDF: 1426HTML: 180 -
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3266PDF: 1336HTML: 2619 -
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1155PDF: 600HTML: 6793 -
CAR-T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA CAR-T and CLL
3506PDF: 1547HTML: 75 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3178PDF: 1420HTML: 5841Fig1-Ag-Pil: 220Ag-Pil Fig.2: 224 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4074PDF: 1576HTML: 928 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
4294PDF: 1481HTML: 1547Untitled: 224 -
Follicular Lymphoma: A Clinicopathological Analysis from a Tertiary care Institute in Southern India
3166PDF: 769HTML: 2938Figure 1a and 1b: 145Figure 2: 155Figure 3: 174Figure 4: 156Figure 5: 160Tables 1-5: 151 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
3982PDF: 1040HTML: 3579Untitled: 174Cneo. Fig.1: 111Untitled: 102Untitled: 125Untitled: 129 -
Aberrant acquisition of T-cell associated markers in plasma cell neoplasms: An aggressive disease with extramedullary involvement and very short survival Aberrant T markers on malignant plasma cells
1517PDF: 386HTML: 203 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7396PDF: 2411HTML: 1720Table 1.: 204Table 2.: 215Table 3.: 195Table 4.: 195 -
Hsa-miR-5581-3p and hsa-miR-542-3p target the F8 gene in hemophilia A without F8 mutations F8 gene is regulated by miRNAs
1105PDF: 483HTML: 224 -
The labyrinth of pyrexia of unknown origin: A case of intravascular B cell lymphoma
1757PDF: 683HTML: 2401Untitled: 150Figure 1 a: 153Figure 1 b: 164Fig 1 c: 145Figure 1 d: 191 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1335PDF: 806HTML: 1022Untitled: 183 -
-
Acquired Hemophilia A successfully treated with rituximab
1915PDF: 1138HTML: 1451Figure 1: 173 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4051PDF: 3342HTML: 198







